Pine Valley Investments Ltd Liability Co trimmed its position in Columbia Research Enhanced Value ETF (NYSEARCA:REVS – Free Report) by 10.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 25,433 shares of the company’s stock after selling 3,039 shares during the quarter. Pine Valley Investments Ltd Liability Co owned approximately 1.41% of Columbia Research Enhanced Value ETF worth $629,000 at the end of the most recent quarter.
Separately, Wealth Enhancement Advisory Services LLC boosted its holdings in shares of Columbia Research Enhanced Value ETF by 22.2% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 38,657 shares of the company’s stock worth $981,000 after buying an additional 7,013 shares during the period.
Columbia Research Enhanced Value ETF Price Performance
Shares of REVS opened at $25.73 on Thursday. The stock has a market cap of $65.61 million, a price-to-earnings ratio of 17.71 and a beta of 0.90. The company has a 50-day moving average of $25.47 and a two-hundred day moving average of $25.49. Columbia Research Enhanced Value ETF has a one year low of $22.56 and a one year high of $27.03.
Columbia Research Enhanced Value ETF Profile
The Columbia Research Enhanced Value ETF (REVS) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of US stocks pulled from the Russell 1000 Value Index. REVS index uses multifactor selection and market cap weighting. REVS was launched on Sep 25, 2019 and is managed by Columbia.
Featured Articles
- Five stocks we like better than Columbia Research Enhanced Value ETF
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Buffett’s on the Sidelines – Should You Follow?
- What is Short Interest? How to Use It
- AST SpaceMobile Stock Surges 17% After Analyst Upgrade
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- 3 Stocks With Triple-Digit PEs That Are Still Worth a Look
Want to see what other hedge funds are holding REVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Columbia Research Enhanced Value ETF (NYSEARCA:REVS – Free Report).
Receive News & Ratings for Columbia Research Enhanced Value ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Columbia Research Enhanced Value ETF and related companies with MarketBeat.com's FREE daily email newsletter.